DEPDC5 and colonic neoplasm: For example, colon cancer cells with homozygous deletion of DEPDC5 exhibited resistance to 5-fluorouracil, a first-line chemotherapeutic in colorectal cancer, and to MK2206, a pan-AKT inhibitor [88].